Hereditary breast and ovarian cancer and other hereditary syndromes: Using technology to identify carriers

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 1732-1737

  Drohan, Brian ^a   Roche, Constance A ^a   Cusack, James C ^a   Hughes, Kevin S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; COMPUTER PROGRAM; DATA ANALYSIS; EARLY DIAGNOSIS; ELECTRONIC MEDICAL RECORD; FAMILIAL CANCER; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HEREDITARY BREAST OVARIAN CANCER SYNDROME; HETEROZYGOTE; HUMAN; INTERNET; OVARY CANCER; PREVALENCE; REVIEW; RISK ASSESSMENT; SYNDROME; UNITED STATES;

EID: 84865125070     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2257-y     Document Type: Review

References (23)

1. Scheuner MT, Yoon PW, Khoury MJ. Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention. Am J Med Gen. 2004;125C: 50-65. (Pubitemid 38140303)
2. Crane RM, Raymond B. Fulfilling the potential of clinical information systems. Permanente J. 2003;7:62-7.
3. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676-89. (Pubitemid 28164626)
4. Wideroff L, Vadaparampil ST, Greene, MH, et al. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42:749-55. (Pubitemid 41475249)
5. Euhus DM. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J. 2001;7:224-32. (Pubitemid 32959422)
6. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet. 1998;62:145-58. (Pubitemid 28093844)
7. Antoniou AC, Cunningham AP, Peto J, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98:1457-66. (Pubitemid 351543573)
8. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111-30. (Pubitemid 38477070)
9. Myriad Genetics Inc. Myriad for professionals. BRCA1 and BRCA2 prevalence tables. https://www.myriadpro.com/bracanalysis-prevalence-tables.
10. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730-6.
11. Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996;14:185-7. (Pubitemid 26338801)
12. Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE. Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21-to 55-year-old women. Genet Med. 2006;8:161-8.
13. Risch HA, McLaughlin JR, Cole DEC, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700-10. (Pubitemid 32203724)
14. US Census Bureau. http://factfinder.census.gov/servlet/QTTable?-bm= y&-geo-id=01000US&-qr-name=DEC-2000-SF1-U-QTP1 &-ds-name=DEC-2000- SF1-U.
15. Kurian AW, Sigal BM, Plevritis SK. Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2009;28:222-31.
16. American Cancer Society. Breast cancer overview. How many women get breast cancer? http://www.cancer.org/cancer/breast cancer/overviewguide/breast- cancer-overview-key-statistics.
17. Myriad Genetics Inc annual reports (10-K) and quarterly reports (10-Q). http://www.getfilings.com/comp/k0000899923.html.
18. Levy DE, Garber JE, Shields AE. Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med. 2009;24:822-8.
19. Feero WG, Bigley MB, Brinner KM, et al. New standards and enhanced utility for family health history information in the electronic health record: an update from the American health information community's family health history multi-stakeholder workgroup. J Am Med Inform Assoc. 2008;15:723-8.
20. Health level seven international. ANSI approved standards. http://www.hl7.org/implement/standards/ansiapproved.cfm.
21. http://www.hughesriskapps.com. Accessed December 2010
22. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994;73:643-51. (Pubitemid 24046606)
23. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81: 1879-86. (Pubitemid 20026073)